# Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)

> **NCT00246935** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 150 (—)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Roflumilast

## Key facts

- **NCT ID:** NCT00246935
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-01
- **Final completion:** 2007-10
- **Target enrollment:** 150 (—)
- **Last updated:** 2016-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00246935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00246935, "Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00246935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*